Celsion Corp (NASDAQ:CLSN)

2.63
Delayed Data
As of May 22
 -0.1701 / -6.07%
Today’s Change
2.15
Today|||52-Week Range
3.73
+12.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$56.0M

Company Description

Celsion Corp. engages in the provision of oncology drug development services. It operates through developing and commercializing chemotherapeutic oncology drugs based on proprietary heat-activated liposomal technology. Its products include ThermoDox, TheraPlas, and TheraSilence. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Contact Information

Celsion Corp.
997 Lenox Drive
Lawrenceville New Jersey 08648
P:(609) 896-9100
Investor Relations:
(609) 482-2455

Employees

Shareholders

Other institutional8.67%
Mutual fund holders5.31%
Individual stakeholders14.18%

Top Executives

Michael H. TardugnoExecutive Chairman, President & CEO
Jeffrey Wayne ChurchCFO, Secretary & SVP-Investor Relations
Nicholas BorysChief Medical Officer & Vice President
Khursheed AnwerChief Scientific Officer & Executive VP
Raj PrabhakarExecutive Director-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account